Patients' ability to treat anaphylaxis using adrenaline autoinjectors: A randomized controlled trial

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 70, Issue 7, 2015, Pages 855-863

  Umasunthar, T ^a,b   Procktor, A ^a,b   Hodes, M ^a,b   Smith, J G ^c   Gore, C ^a,b   Cox, H E ^a,b   Marrs, T ^d   Hanna, H ^a,b   Phillips, K ^a,b   Pinto, C ^a,b   Turner, P J ^a   Warner, J O ^a,b   Boyle, R J ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

adrenaline; anaphylaxis; autoinjector; food allergy; human factors research

Indexed keywords

ADRENALIN; ALPHA AMYLASE SALIVA ISOENZYME; AMYLASE; EPINEPHRINE; VASOCONSTRICTOR AGENT;

ADULT; ANAPHYLAXIS; ANXIETY; ARTICLE; CHILD; CONTROLLED STUDY; EPINEPHRINE AUTOINJECTOR; FEMALE; FOOD ALLERGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; CLINICAL TRIAL; DRUG SELF ADMINISTRATION; FOOD HYPERSENSITIVITY; INFANT; INJECTION; METABOLISM; PRESCHOOL CHILD; SALIVARY GLAND; TREATMENT OUTCOME;

ALPHA-AMYLASES; ANAPHYLAXIS; CHILD; CHILD, PRESCHOOL; EPINEPHRINE; FEMALE; FOOD HYPERSENSITIVITY; HUMANS; INFANT; INJECTIONS; MALE; SALIVARY ALPHA-AMYLASES; SALIVARY GLANDS; SELF ADMINISTRATION; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 84931564539     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12628     Document Type: Article

References (18)

1. Turner PJ, Gowland MH, Sharma V, Ierodiakonou D, Harper N, Garcez T, et al., Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data. J Allergy Clin Immunol 2015; 135: 956-963.
2. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, et al., Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117: 391-397.
3. Muraro A, Roberts G, Worm M, Bilò MB, Brockow K, Fernández Rivas M, et al., Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy 2014; 69: 1026-1045.
4. Gold MS, Sainsbury R,. First aid anaphylaxis management in children who were prescribed an adrenaline autoinjector device (EpiPen). J Allergy Clin Immunol 2000; 106: 171-176.
5. Sicherer SH, Forman JA, Noone SA,. Use assessment of self-administered adrenaline among food-allergic children and pediatricians. Pediatrics 2000; 105: 359-362.
6. Mehr S, Robinson M, Tang M,. Doctor-how do I use my EpiPen? Pediatr Allergy Immunol 2007; 18: 448-452.
7. Noimark L, Wales J, Du Toit G, Pastacaldi C, Haddad D, Gardner J, et al., The use of adrenaline autoinjectors by children and teenagers. Clin Exp Allergy 2012; 42: 284-292.
8. Simons FE, Edwards ES, Read EJ Jr, Clark S, Liebelt EL,. Voluntarily reported unintentional injections from adrenaline auto-injectors. J Allergy Clin Immunol 2010; 125: 419-423.
9. Strahler J, Mueller A, Rosenloecher F, Kirschbaum C, Rohleder N,. Salivary alpha-amylase stress reactivity across different age groups. Psychophysiology 2010; 47: 587-595.
10. Fagerland MW, Lydersen S, Laake P,. The McNemar test for binary matched-pairs data: mid-p and asymptotic are better than exact conditional. BMC Med Res Methodol 2013; 13: 91.
11. European Medicines Agency. Adrenaline auto-injectors 2014. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Adrenaline-auto-injectors/human-referral-000367.jsp&mid=WC0b01ac05805c516f.
12. Sicherer SH, Vargas PA, Groetch ME, Christie L, Carlisle SK, Noone S, et al., Development and validation of educational materials for food allergy. J Pediatr 2012; 160: 651-656.
13. Salter SM, Loh R, Sanfilippo FM, Clifford RM,. Demonstration of adrenaline autoinjectors (EpiPen and Anapen) by pharmacists in a randomised, simulated patient assessment: acceptable, but room for improvement. Allergy Asthma Clin Immunol 2014; 10: 49.
14. Osborne NJ, Koplin JJ, Martin PE, Gurrin LC, Lowe AJ, Matheson MC, et al., Prevalence of challenge-proven IgE-mediated food allergy using population-based sampling and predetermined challenge criteria in infants. J Allergy Clin Immunol 2011; 127: 668-676.
15. Dhami S, Panesar SS, Roberts G, Muraro A, Worm M, Bilò MB, et al., Management of anaphylaxis: a systematic review. Allergy 2014; 69: 168-175.
16. Rawas-Qalaji M, Rachid O, Mendez BA, Losada A, Simons FE, Simons KJ,. Adrenaline (adrenaline) microcrystal sublingual tablet formulation: enhanced absorption in a preclinical model. J Pharm Pharmacol 2015; 67: 20-25.
17. School Access to Emergency Adrenaline Act Public Law 113-48. 127 STAT 575 http://www.gpo.gov/fdsys/pkg/PLAW-113publ48/pdf/PLAW-113publ48.pdf: US government Printing Office, 2013.
18. Caffrey SL, Willoughby PJ, Pepe PE, Becker LB,. Public use of automated external defibrillators. N Engl J Med 2000; 347: 1242-1247.